Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling. Tran QM, Soda J, Siraj A, Moore S, et al. Vaccine 2022 Nov 21:S0264-410X(22)01426-8. doi: 10.1016/j.vaccine.2022.

Read + Share

Amedeo Smart

Independent Medical Education

Tran QM, Soda J, Siraj A, Moore S, et al. Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling. Vaccine 2022 Nov 21:S0264-410X(22)01426-8. doi: 10.1016/j.vaccine.2022.
PMID: 36424258